The anti-aromatase effect of progesterone and of its natural metabolites 20α- And 5α-dihydroprogesterone in the MCF-7aro breast cancer cell line

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2129-2133

  Pasqualini, Jorge R ^a   Chetrite, G ^a,b  

^a Institut de Puericulture   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Aromatase; Breast cancer; MCF 7aro cells; Progesterone

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; ANDROSTANOLONE; AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; PROGESTERONE; TESTOSTERONE; TRITIUM;

ARTICLE; BREAST; BREAST CANCER; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; STATISTICAL SIGNIFICANCE; THIN LAYER CHROMATOGRAPHY;

20-ALPHA-DIHYDROPROGESTERONE; 5-ALPHA-DIHYDROPROGESTERONE; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; HUMANS; PROGESTERONE; TESTOSTERONE; TRITIUM;

EID: 49049100680     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pike MC, Spicer DV, Dahmoush L and Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35, 1993.
2. Pasqualini J and Kind F. Hormones and the Fetus. Pergamon Press (Oxford), pp. 1-437, 1986.
3. Pasqualini JR: Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 97: 401-415, 2005.
4. Tseng L and Gurpide E: Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97: 825-833, 1975.
5. Wiebe JP, Muzia D, Hu J, Szwajcer D, Hill SA and Seachrist JL: The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Res 60: 936-943, 2000.
6. Wiebe JP, Lewis MJ, Cialacu V, Pawlak KJ and Zhang G: The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics. J Steroid Biochem Mol Biol 93: 201-208, 2005.
7. Brodie AMH and Pasqualini JR (eds.): 'Proceedings of the VIII International Aromatase Conference "AROMATASE 2006", Baltimore, Maryland, USA. J Steroid Biochem Molec Biol 106: 1-186, 2007.
8. Brodie AMH: Aromatase inhibitors and their application to the treatment of breast cancer. In: Breast Cancer Prognosis, Treatment and Prevention (2nd Edition). Pasqualini JR (ed.). New York, Informa Healthcare, pp. 157-168, 2008.
9. Miller WR and Pasqualini JR (eds.): 'Proceedings of the VII International Aromatase Conference "AROMATASE 2004", Edinburg, Scotland, UK. J Steroid Biochem Molec Biol 95: 1-187, 2005.
10. Ryan PD and Goss PE: Aromatase inhibition and breast cancer: update of clinical applications. In: Breast Cancer Prognosis, Treatment and Prevention (2nd Edition). Pasqualini JR (ed.). New York, Informa Healthcare, pp. 169-180, 2008.
11. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M and Maloche C: Concentrations of estrone, estradiol, estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 81: 1460-1464, 1996.
12. Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F and Pasqualini JR: Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72: 23-27, 2000.
13. Sun XZ, Zhou D and Chen S: Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells. J Steroid Biochem Mol Biol 63: 29-36, 1997.
14. Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315-323, 1956.
15. Wiebe JP: Progesterone metabolites in breast cancer. Endocr Relat Cancer 13: 717-738, 2006.
16. Pawlak KJ and Wiebe JP: Regulation of estrogen receptor (ER) levels in MCF-7 cells by progesterone metabolites. J Steroid Biochem Mol Biol 107: 172-179, 2007.
17. Lewis MJ, Wiebe JP and Heathcote JG: Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4: 27, 2004.
18. Wiebe JP and Lewis MJ: Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231.T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. BMC Cancer 3: 9, 2003.
19. Nguyen BL, Chetrite G and Pasqualini JR: Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020). Breast Cancer Res Treat 34: 139-146, 1995.
20. Pasqualini JR, Chetrite G, Nguyen BL, Maloche C, Delalonde L, Talbi M, Feinstein MC, Blacker C, Botella J and Paris J: Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J Steroid Biochem Mol Biol 53: 407-412, 1995.
21. Liehr JG and Ricci MJ: 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93: 3294-3296, 1996.
22. Gupta M, McDougal A and Safe S: Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 67: 413-419, 1998.
23. Castagnetta LA, Granata OM, Traina A, Ravazzolo B, Amoroso M, Miele M, Bellavia V, Agostara B and Carruba G: Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin Cancer Res 8: 3146-3155, 2002.
24. Lippert C, Seeger H and Mueck AO: The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci 72: 877-883, 2003.
25. Zhu BT and Conney AH: Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 58: 2269-2277, 1998.
26. Seeger H, Huober J, Wallwiener D and Mueck AO: Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Horm Metab Res 36: 277-280, 2004.
27. Salama SA, Jamaluddin M, Kumar R, Hassan MH and Al-Hendy A: Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms. J Steroid Biochem Mol Biol 107: 253-261, 2007.
28. Pawlak KJ, Zhang G and Wiebe JP: Membrane 5alpha-pregnane-3,20-dione (5alphaP) receptors in MCF-7 and MCF-10A breast cancer cells are up-regulated by estradiol and 5alphaP and down-regulated by the progesterone metabolites, 3alpha-dihydroprogesterone and 20alpha-dihydroprogesterone, with associated changes in cell proliferation and detachment. J Steroid Biochem Mol Biol 97: 278-288, 2005.
29. Dressing GE and Thomas P: Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer. Steroids 72: 111-116, 2007.
30. Wiebe JP, Souter L and Zhang G: Dutasteride affects progesterone metabolizing enzyme activity/expression in human breast cell lines resulting in suppression of cell proliferation and detachment. J Steroid Biochem Mol Biol 100: 129-140, 2006.
31. Pasqualini JR and Chetrite G: Paradoxical effect of estradiol: it can block its own bioformation in human breast cancer cells. J Steroid Biochem Mol Biol 78: 21-24, 2001.
32. Chetrite GS, Cortes-Prieto JC, Philippe JC and Pasqualini JR: Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues. J Steroid Biochem Mol Biol 104: 289-292, 2007.
33. Pasqualini JR and Chetrite GS: Estradiol as an anti-aromatase agent in human breast cancer cells. J Steroid Biochem Mol Biol 98: 12-17, 2006.
34. Chetrite GS and Pasqualini JR: The selective estrogen enzyme modulator (SEEM) in breast cancer. J Steroid Biochem Mol Biol 76: 95-104, 2001.